---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-008484"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:04:47.831229+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision receives $250K 8% note from CEO entity due Aug 30, 2024

## Summary
- Entity controlled by CEO David A. Jenkins loans $250K at 8% interest, maturing August 30, 2024.
- Note adds to $500K loan in May 2024 and $150K loan in June 2024 from same source.
- Proceeds from S-1 securities sale expected to repay the note.
- Jenkins and affiliates hold >10% common stock, convertible preferred, stock options, and 11.77% royalty on LockeT sales.

## SEC filing metadata
- accession: 0001654954-24-008484
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424008484/0001654954-24-008484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424008484/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-008484
- JSON: https://secwatch.observer/filing/0001654954-24-008484.json
- Plain text: https://secwatch.observer/filing/0001654954-24-008484.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.